{
    "RADCURE-3607": {
        "question": "Age: 73.6, Sex: Female, ECOG PS: ECOG 1, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Hypopharynx, Subsite: Post-cricoid, T: T1, N: N2c, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: Y, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases involving hypopharyngeal sites. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), and soft tissues of the neck.\n- The airway appears patent but there is a masked region of interest (ROI) highlighted in purple and blue.\n- The purple ROI is located anteriorly, likely corresponding to the hypopharyngeal or laryngeal region.\n- The blue ROI is located inferiorly and posteriorly, possibly involving the base of tongue or oropharyngeal region.\n- No obvious gross bone destruction or large mass effect is seen in this single slice.\n- The masked ROIs suggest areas of pathological interest, possibly tumor or involved lymph nodes.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates: [[253, 235, 68, 253, 274, 87], [271, 249, 117, 271, 297, 140]]\n\n- These coordinates define two volumetric regions within the scan.\n- The first bounding box (253,235,68 to 253,274,87) likely corresponds to the purple ROI in the anterior hypopharyngeal/laryngeal region.\n- The second bounding box (271,249,117 to 271,297,140) corresponds to the blue ROI, more posterior and inferior, possibly base of tongue or oropharynx.\n- Both bounding boxes are relatively small volumes, consistent with localized tumor or involved lymph nodes.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 73.6-year-old female with squamous cell carcinoma of the hypopharynx, post-cricoid subsite.\n- Tumor stage T1 indicates a small primary tumor.\n- N2c nodal status indicates bilateral or contralateral lymph node involvement.\n- M0 indicates no distant metastasis.\n- Stage IVA reflects locally advanced disease due to nodal involvement.\n- HPV negative status is associated with poorer prognosis compared to HPV positive.\n- ECOG 1 indicates the patient is ambulatory and capable of self-care but restricted in strenuous activity.\n- Non-smoker status is favorable but the presence of a second cancer (2nd Ca: Y) complicates prognosis.\n- Treatment is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- No local, regional, or distant recurrence noted at the time of imaging.\n- The masked ROIs and bounding boxes correspond to the primary tumor and involved lymph nodes.\n- Given the small primary tumor but advanced nodal disease, the risk of regional failure is significant.\n- Radiation alone without chemotherapy in stage IVA may be suboptimal, potentially impacting survival.\n- The presence of a second cancer may further reduce overall survival probability.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows localized hypopharyngeal squamous cell carcinoma with bilateral nodal involvement.\n- The masked ROIs and bounding boxes correspond to the primary tumor and involved lymph nodes.\n- The patient's clinical profile (T1N2cM0, HPV negative, stage IVA) and treatment (RT alone) suggest a moderate to high risk of disease recurrence and mortality.\n- The presence of a second cancer and lack of chemotherapy further worsen prognosis.\n- Overall, the survival probability is guarded, with significant risk of mortality despite treatment.\n\nAnswer:  \n('Answer:Dead',)",
        "Round 1-role-comment": "radiation oncologist:dead",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes.  \nType of expert needed: Medical oncologist and Head and Neck surgeon.  \nReason: Given the patient's stage IVA hypopharyngeal squamous cell carcinoma with bilateral nodal involvement and HPV negative status, multidisciplinary input is essential to evaluate the potential benefit of systemic therapy (chemotherapy or immunotherapy) and surgical options. My expertise is limited to radiation therapy planning and dosing, so input from medical oncology and surgical oncology is needed to optimize overall treatment strategy and improve prognosis.",
        "Round 2-Turn 1-gap_identified-assistant": "The unique, useful, and specific expert recommendations extracted are:\n\n- Consult a Medical Oncologist  \n- Consult a Head and Neck Surgeon",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers. - Hierarchy: Medical Oncologist == Radiation Oncologist\n2. Head and Neck Surgeon - Your expertise is strictly limited to surgical evaluation and management of hypopharyngeal squamous cell carcinoma, including considerations for secondary cancers. - Hierarchy: Head and Neck Surgeon == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), and surrounding soft tissues.\n- The airway appears patent without obvious obstruction.\n- There are two masked regions of interest (ROIs) highlighted in purple and blue.\n- The purple ROI is located anteriorly, near the hypopharyngeal or post-cricoid region.\n- The blue ROI is located more inferiorly and posteriorly, likely involving the base of tongue or oropharyngeal area.\n- No gross bone destruction or large mass effect is evident in this slice.\n- The ROIs likely represent pathological areas such as the primary tumor and involved lymph nodes.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates: [[253, 235, 68, 253, 274, 87], [271, 249, 117, 271, 297, 140]]\n\n- The first bounding box (253,235,68 to 253,274,87) corresponds spatially to the purple ROI in the anterior hypopharyngeal/post-cricoid region, consistent with the primary tumor site.\n- The second bounding box (271,249,117 to 271,297,140) corresponds to the blue ROI, located posteriorly and inferiorly, likely representing involved lymph nodes in the oropharyngeal or base of tongue region.\n- Both bounding boxes are relatively small, consistent with localized tumor and nodal involvement.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 73.6-year-old female with squamous cell carcinoma of the hypopharynx, post-cricoid subsite.\n- Tumor stage T1 indicates a small primary tumor.\n- N2c nodal status indicates bilateral or contralateral lymph node involvement, which is a poor prognostic factor.\n- M0 indicates no distant metastasis.\n- Stage IVA reflects locally advanced disease due to nodal involvement.\n- HPV negative status is associated with worse prognosis compared to HPV positive tumors.\n- ECOG 1 indicates the patient is ambulatory but with some limitation in strenuous activity.\n- Non-smoker status is favorable but the presence of a second cancer complicates prognosis.\n- Treatment was radiation therapy alone (70 Gy in 35 fractions) without chemotherapy.\n- No local, regional, or distant recurrence noted at the time of imaging.\n- Radiation alone in stage IVA disease is generally suboptimal; combined chemoradiation is standard to improve survival.\n- The presence of bilateral nodal disease and a second cancer increases the risk of treatment failure and mortality.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding boxes confirm a small primary hypopharyngeal tumor with bilateral nodal involvement.\n- The patient's clinical profile (T1N2cM0, HPV negative, stage IVA) and treatment with radiation alone suggest a high risk of disease recurrence and mortality.\n- The presence of a second cancer further worsens prognosis.\n- Overall, despite no current evidence of recurrence, the survival probability is guarded and the risk of death is significant.\n\nAnswer:  \n('Answer:Dead',)",
        "Round 2-Turn 1-gap_recruited_assessment-head and neck surgeon": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal section of the head and neck region, showing bony structures (cervical vertebrae), airway, and soft tissues.\n- The airway lumen is visible and appears patent without gross obstruction.\n- There is a masked region of interest (ROI) highlighted in two colors: purple and blue.\n- The purple ROI is located anteriorly, near the hypopharyngeal or post-cricoid region, consistent with the primary tumor site.\n- The blue ROI is located more inferiorly and posteriorly, likely corresponding to lymph node regions or secondary pathological involvement.\n- No obvious gross bone erosion or destruction is seen in this slice.\n- No large mass effect or airway compromise is evident.\n- The ROIs suggest localized tumor involvement and possible nodal disease.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates: [[253, 235, 68, 253, 274, 87], [271, 249, 117, 271, 297, 140]]\n\n- The first bounding box (253,235,68 to 253,274,87) corresponds spatially to the purple ROI in the anterior hypopharyngeal/post-cricoid region, consistent with the primary tumor.\n- The second bounding box (271,249,117 to 271,297,140) corresponds to the blue ROI, located posteriorly and inferiorly, likely representing involved lymph nodes in the neck.\n- Both bounding boxes are relatively small, indicating localized tumor and nodal involvement rather than extensive disease.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 73.6-year-old female with squamous cell carcinoma of the hypopharynx, specifically the post-cricoid subsite.\n- Tumor staging: T1 (small primary tumor), N2c (bilateral or contralateral lymph node involvement), M0 (no distant metastasis).\n- Overall stage IVA due to nodal involvement.\n- HPV negative status, which is associated with a less favorable prognosis compared to HPV positive tumors.\n- ECOG performance status 1 indicates the patient is ambulatory but with some limitations.\n- Non-smoker status is favorable but the presence of a second primary cancer complicates prognosis.\n- Treatment consisted of radiation therapy alone (70 Gy in 35 fractions) without chemotherapy.\n- No evidence of local, regional, or distant recurrence at the time of imaging.\n- The presence of bilateral nodal disease (N2c) increases the risk of regional failure.\n- Radiation alone without concurrent chemotherapy in stage IVA hypopharyngeal cancer is generally considered suboptimal and may reduce survival chances.\n- The second cancer presence further worsens overall prognosis.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding boxes confirm a small primary hypopharyngeal tumor with bilateral nodal involvement.\n- The patient's clinical profile (T1N2cM0, HPV negative, stage IVA) and treatment modality (radiation alone) suggest a guarded prognosis.\n- The absence of chemotherapy and presence of a second cancer increase the risk of treatment failure and mortality.\n- Despite no current evidence of recurrence, the overall survival probability is reduced due to advanced nodal disease and treatment limitations.\n\nAnswer:  \n('Answer:Dead',)",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-head and neck surgeon": "No",
        "Round 2-role-comment": "radiation oncologist:dead|medical oncologist:dead|head and neck surgeon:dead",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer:Dead',)"
    }
}